Men's immune response to brain protein may explain their higher rates of Parkinson's disease
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson's disease.
The American Journal of Managed Care1d
Adaptive Deep Brain Stimulation Technology Receives FDA Approval for Parkinson Disease
The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...
Studies of Parkinson's disease have long overlooked Pacific populations—meta-analysis shows why that must change
A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...
Healio2d
FDA approves first adaptive deep brain stimulation system for Parkinson’s disease
The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in ...
News Medical on MSN3d
This New Treatment Can Adjust to Parkinson’s Symptoms in Real Time
The FDA has approved an adaptive deep brain stimulation (aDBS) treatment for people with with Parkinson’s disease, making this groundbreaking technology available to people nationwide.
FierceBiotech3d
FDA approves Medtronic’s adaptive deep-brain stimulator for Parkinson’s disease
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
News Medical on MSN2d
Can coffee push back Parkinson’s? New study uncovers key genetic link
Higher coffee consumption is causally linked to delayed onset of Parkinson’s disease but does not affect disease risk or ...
China Focus: Parkinson's possible to be blocked thanks to Chinese scientists' breakthrough research
Chinese scientists have discovered a novel therapeutic target for Parkinson's disease, a neurodegenerative condition ...
emjreviews.com1d
Teleneurorehabilitation: A Safe, Effective Alternative for Parkinson’s Treatment
Telemedicine helps Parkinson’s patients—safe, effective rehab via video calls. Discover the TELEPARK trial’s promising results.
In Parkinson’s fight, Medtronic’s first-in-the-world adaptive therapy feature wins FDA approval
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Labroots17h
Novel Cell Marker Increases Risk for Parkinson's Disease in Men
Millions of people worldwide are diagnosed and treated for Parkinson’s disease (PD). Unfortunately, in the U.S., there are about 1 million people wit | Immunology ...